Regeneron’s Eylea: Pulling Open the Curtain on Drug Costs

Doris is 85 and suffers from moisture build up in her eye, what some call wet eye.   She is on Medicare and gets treated with Eylea, a Regeneron product, every 4-5 weeks.  Each treatment costing $6,200.   That is more than $70,000 per year even though Doris never made more than $40,000 while working. … Continue reading Regeneron’s Eylea: Pulling Open the Curtain on Drug Costs

Sovereign Apartment Forced Eviction Highlights Tax Inequity

In late 2014 the tax exempt Oregon Historical Society sold the Sovereign Apartment building, after owning it more than 30 years.  The Society maintains an outstanding board of directors and this was clearly a difficult decision. As part of the sale the society negotiated a long-term lease for itself yet its 44 tenants were last … Continue reading Sovereign Apartment Forced Eviction Highlights Tax Inequity

Blackstone’s Tony James and Renaissance Technologies Jim Simons, Top Financial Engineers, Back Hillary Clinton Campaign

Disclosure:  This post is the first of several regarding the 2016 Presidential candidates.  One post will be done on each major candidate and the focus will be their primary financial backers and their respective foundations.  Bill Parish maintains no ties to any candidate nor does he have knowledge of any client owning positions in private … Continue reading Blackstone’s Tony James and Renaissance Technologies Jim Simons, Top Financial Engineers, Back Hillary Clinton Campaign

The Oregonian Reports on Valuation Concerns Regarding PERS Private Equity Investments

In a front page story Sunday May 20, 2012, Ted Sickinger of the Oregonian provided a detailed review of private equity valuation concerns.  This portfolio of opaque investments has grown substantially and poses unique risks to Oregonian PERS participants.  In his article, Sickinger notes this analysis is based upon original Parish & Company research. Although … Continue reading The Oregonian Reports on Valuation Concerns Regarding PERS Private Equity Investments